Výsledky vyhledávání - "Sukru, Ozaydın"

The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study

Autor: Muhammet, Ali Kaplan, Zeynep, Oruc, Mahmut, Gumus, Sukru, Ozaydın, Emin Tamer, Elkiran, Nur Sener, Dinc, Abdullah, Sakin, Veli, Berk, Tulay, Akman, Aydin, Aytekin, Dogan, Yazilitas, Faysal, Dane, Goksen Inanc, Imamoglu, Erdem, Cubukcu, Abdurrahman, Isikdogan

Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 24(3)

To analyze the reliability and the effectiveness of chemotherapy and prognostic factors for survival in patients with HER2 (human epidermal growth receptor 2) negative early-stage breast cancer treated with adjuvant sequential anthracycline-based che

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0d10beeef5c4f59deaec510df04ec6d2
https://pubmed.ncbi.nlm.nih.gov/31424664

Zobrazit plný text záznamu

An overview of high dose chemotherapy with autologous stem cell rescue for germ cell tumors in current practice

Autor: Sukru, Ozaydın, Ugur, Sahin, Nuri, Karadurmus, Fikret, Arpaci, Taner, Demirer

Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 22(2)

Testicular cancer is a frequent tumor of adolescent and young adult males. Chemotherapy has been reported to provide cure rates as high as 80% even in the presence of advanced testicular cancer. Studies regarding testicular cancer started after the a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fdb50fd51f7d3fa0720abd83b5907bbb
https://pubmed.ncbi.nlm.nih.gov/28534349

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání